Suppression of lymphoproliferation by alveolar macrophages in the guinea pig

Tubercle and Lung Disease

Volumn 79, Issue 2, 1998, Pages 119-126

  Zhang, X ^b   McMurray, David N ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; GAMMA INTERFERON; HYDROGEN PEROXIDE; INDOMETACIN; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CELL CONTACT; COCULTURE; CONTROLLED STUDY; FEMALE; GUINEA PIG; LISTERIA MONOCYTOGENES; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 2942737619     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0014     Document Type: Article

References (32)

1. 1. Rich E A, Tweardy D J, Fujiwara H, Ellner J J. Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 1987; 136: 258-265.
2. 2. Ettensohn D B, Roberts N J Jr. Human alveolar macrophages support of lymphocyte response to mitogens and antigens: analysis and comparisons with autologous peripheral blood-derived monocytes and macrophages. Am Rev Respir Dis 1983; 128: 516-522.
3. 3. Yeager H Jr, Sweeney J A, Herscowitz H B, Barsoum I S, Kagan E. Modulation of mitogen-induced proliferation of autologous peripheral blood lymphocytes by human alveolar macrophages. Infect Immun 1982; 38: 260-266.
4. 4. McCombs C C, Michalski J P, Westerfield B T, Light R W. Human alveolar macrophages suppress the proliferative response of peripheral blood lymphocytes. Chest 1982; 82: 266-271.
5. 5. Toews G B, Vial W C, Dunn M M et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol 1984; 132: 181-186.
6. 6. Holt P G. Alveolar macrophages. IV. Interspecies differences in activity in proliferating lymphocyte cultures. Cell Immuno 1980; 50: 210-215.
7. 7. Holt P G. Alveolar macrophages. II. Inhibition of lymphocyte proliferation by purified macrophages from rat lung. Immunology 1979; 37: 429-436.
8. 8. Holt P G. Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. Clin Exp Immunol 1986; 63: 261-270.
9. 9. Holt P G. Inhibitory activity of unstimulated alveolar macrophages on T-lymphocyte blastogenic response. Am Rev Respir Dis 1978; 118: 791-793.
10. 10. Holt P G. Alveolar macrophages. III. Studies on the mechanism of inhibition of T cell proliferation. Immuno 1979; 37: 437-445.
11. 11. Gorenberg D J, Daniele R P. The alveolar macrophage: its capacity as an accessory cell in mitogen-stimulated proliferation of guinea pig lymphocytes. Cell Immunol 1978; 36: 115-127.
12. 12. Kaelin R M, Center D M, Grant M M, Bernardo J. Production of lymphocyte chemokinetic activity by stimulated alveolar macrophages. Exp Lung Res 1986; 10: 171-186.
13. 13. Greneder D K, Risenthal A S. Macrophage activation of allogeneic lymphocyte proliferation in the guinea pig mixed leukocyte culture. J Immunol 1975; 114: 1541-1547.
14. 14. Lipscomb M F, Toews G B, Lyons C R, Uhr J W. Antigen presentation by guinea pig alveolar macrophages. J Immunol 1981; 126: 286-291.
15. 15. Metzger Z, Hoffeld J T, Oppenheim J J. Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol 1980; 124: 983-988.
16. 16. Moore S A, Stricter R M, Rolfe M W, Standiford T J, Burdick M D, Kunkel S L. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1992; 6: 569-575.
17. 17. Albina J E, Henry W J. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J Surg Res 1991; 50: 403-408.
18. 18. Kawabe T, Isobe K-I, Hasegawa Y, Nakashima I, Shimokata K. Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunol 1992; 76: 72-78.
19. 19. Goodwin J S, Baukhurst A D, Messner R P. Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 1977; 146: 1719-1734.
20. 20. Upham J W, Strickland D H, Bilyk N, Robinson B W S, Holt P G. Alveolar macrophages from humans and rodents selectively inhibit T cell proliferation but permit T cell activation and cytokine secretion. Immunol 1995; 84: 142-147.
21. 21. McMurray D N, Kimball M S, Tetzlaff C L, Mintzer C L. Effects of protein deprivation and BCG vaccination on alveolar macrophage function in pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 1081-1085.
22. 22. Holian A, Dauber J H, Diamond M S, Daniele R P. Separation of bronchoalveolar cells from the guinea pig on continuous gradients of Percoll: functional properties of fractionated lung macrophages. J Reticuloendothel Soc 1983; 33: 157-164.
23. 23. McMurray D N, Mintzer C L, Bartow R A, Parr R L. Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis. Infect Immun 1989; 57: 2606-2611.
24. 24. Isobe K, Nakashima I. Feedback suppression of staphylococcal enterotoxin-stimulated T-lymphocyte proliferation by macrophages through inductive nitric oxide synthesis. Infect Immun 1992; 60: 4832-4837.
25. 25. Albina J E, Abate J A, Henry W J. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. J Immunol 1991; 147: 144-148.
26. 26. Al-Ramadi B K, Meissler J J, Huang D, Eisenstein T K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol 1992; 22: 2249-2254.
27. 27. Jun C, Choi B, Hoon-Ryu B et al. Synergistic cooperation between phorbol ester and IFN-γ for induction of nitric oxide synthesis in murine peritoneal macrophages. J Immunol 1994; 153: 3684-3690.
28. 28. Hibbs J B Jr, Taintor R R, Vavoin Z, Rachlin E M. Nitric oxide; a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87-94.
29. 29. Chan J, Xing Y, Magliozzo R S, Bloom B R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111-1122.
30. 30. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993; 167: 1358-1363.
31. 31. Rich E A, Cooper C, Toossi Z et al. Requirement for cell-to-cell contact for the immunosuppressive activity of human alveolar macrophages. Am J Respir Cell Mol Biol 1991; 4: 287-294.
32. 32. Daniele R P, Altose M D, Rowlands D T Jr. Immunocompetent cells from the lower respiratory tract of normal human lungs. J Clin Invest 1975; 56: 986-995.